Friday, October 2, 2026
27 C
Bengaluru

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

With over three decades of experience in the pharmaceutical and healthcare industry, Shakul brings extensive expertise in vaccines, commercial leadership, business transformation, and strategic growth. His leadership journey has been focused on transforming businesses through strategic enablement, process efficiency, people development, market expansion, resource optimization, digital innovation, cultural integration, and effective P&L management.

In his current role at Indian Immunologicals Limited, he is responsible for leading the human vaccines business while driving strategic business initiatives and digital transformation. His focus includes fostering innovation, developing new concepts, and strengthening the organization’s capabilities in the vaccines segment.

Prior to this role, Shakul served as Vice President – Human Health at Indian Immunologicals, where he played a key role in establishing and expanding the company’s human vaccines, hormones, and wellness product portfolio. He also led large commercial teams across sales, marketing, learning and development, and business operations.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

India’s anaemia challenge is not simply about access to...

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

A Tale of Two Cities: Peptides and Prescriptions

What our health choices reveal about education, access and...

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...

Topics

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

A Tale of Two Cities: Peptides and Prescriptions

What our health choices reveal about education, access and...

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...

Medical Reps—Lessons From The West: The Old Model is Dead

The Core Conclusion The Western pharma industry is not simply...

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

How wearables, diagnostics, AI and continuous monitoring are moving...
spot_img

Related Articles

spot_imgspot_img